Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC1R | Q01726 | 9/20 | 0.48 |
| ▸ | MC4R | P32245 | 9/20 | 0.48 |
| ▸ | MC5R | P33032 | 1/20 | 0.32 |
| ▸ | MC3R | P41968 | 1/20 | 0.32 |
| ▸ | YAP1 | P46937 | 5/20 | 0.31 |
| ▸ | REN | P00797 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154189 | 0.89 | MC1R (0.58) | MC1RMC4RMC5RMC3R | |
| SCHEMBL2156516 | 0.87 | MC1R (0.47) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL20450416 | 0.84 | MC1R (0.61) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL1313222 | 0.84 | MC1R (0.61) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL1310472 | 0.84 | MC1R (0.60) | MC1RMC4RMC5RMC3R | |
| SCHEMBL1310087 | 0.84 | MC1R (0.64) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL20450359 | 0.83 | MC1R (0.58) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL1310689 | 0.83 | MC1R (0.58) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL1312855 | 0.81 | MC1R (0.63) | MC1RMC4RMC5RMC3RYAP1 | |
| SCHEMBL1310154 | 0.81 | MC1R (0.63) | MC1RMC4RMC5RMC3RYAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2342194-A1 | OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | Galderma Research & Development (FR) | 2011-07-13 | — | — | EP | claimed |